Roche-partnered Scenic Biotech snags $31M to study 3 rare disease drugs

Roche-partnered Scenic Biotech has scored a $31 million series A financing round and plans to take three

Related Keywords

,Roche ,Emerging Biopharma ,Venture Capital Vc ,Niemann Pick Typec Disease ,Rare Diseases ,Genetic Diseases ,Scenic Biotech ,Venture Capital ,Fierce Biotech Homepage ,Biotech ,